Dongjie Yang

Wuxi, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cuproptosis and prostate cancer: from molecular mechanisms and microenvironment remodeling to precision therapy.

Cuproptosis and prostate cancer: from molecular mechanisms and microenvironment remodeling to precision therapy.

Journal: Frontiers in oncology

Published: May 08, 2026

Association between the CCR2-V64I polymorphism and cancer susceptibility: a meta-analysis of 20 case-control studies.

Association between the CCR2-V64I polymorphism and cancer susceptibility: a meta-analysis of 20 case-control studies.

Journal: Scientific reports

Published: April 01, 2026

Label-free molecular profiling of cancer using Raman spectroscopy: from fundamentals to clinical applications.

Label-free molecular profiling of cancer using Raman spectroscopy: from fundamentals to clinical applications.

Journal: Frontiers in oncology

Published: March 03, 2026

TLN1 interacts with NGFR and suppresses the development of castration-resistant prostate cancer by upregulating NGFR.

TLN1 interacts with NGFR and suppresses the development of castration-resistant prostate cancer by upregulating NGFR.

Journal: Frontiers in immunology

Published: February 02, 2026

Novel Strategies for Precision Diagnosis and Treatment of Prostate Cancer Based on Multifunctional Nanocarrier Systems.

Novel Strategies for Precision Diagnosis and Treatment of Prostate Cancer Based on Multifunctional Nanocarrier Systems.

Journal: International journal of nanomedicine

Published: November 05, 2025

Types of biomimetic materials and their emerging clinical applications in the field for prostate cancer.

Types of biomimetic materials and their emerging clinical applications in the field for prostate cancer.

Journal: International journal of biological macromolecules

Published: May 06, 2025

Targeting the PI3K-AKT pathway to alleviate 6PPDQ-induced cognitive impairment associated with metabolic syndrome.

Targeting the PI3K-AKT pathway to alleviate 6PPDQ-induced cognitive impairment associated with metabolic syndrome.

Journal: Ecotoxicology and environmental safety

Published: April 21, 2025

Targeting the ac4C 'Writer' NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8+ T cells and tumor cells.

Targeting the ac4C 'Writer' NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8+ T cells and tumor cells.

Journal: Cell death & disease

Published: April 01, 2025

Protein arginine methyltransferase 7 regulates the cell cycle and promotes the progression of prostate cancer.

Protein arginine methyltransferase 7 regulates the cell cycle and promotes the progression of prostate cancer.

Journal: Oncology letters

Published: February 05, 2025

NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4-acetylated LAMB3-mediated FAK/ERK pathway.

NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4-acetylated LAMB3-mediated FAK/ERK pathway.

Journal: Cancer communications (London, England)

Published: October 22, 2024

NAT10 promotes hepatocellular carcinoma progression by modulating the ac4C-DDIAS-PI3K-Akt axis.

NAT10 promotes hepatocellular carcinoma progression by modulating the ac4C-DDIAS-PI3K-Akt axis.

Journal: Scientific reports

Published: May 24, 2024

Stimuli-sensitive biomimetic nanoparticles for the inhibition of breast cancer recurrence and pulmonary metastasis.

Stimuli-sensitive biomimetic nanoparticles for the inhibition of breast cancer recurrence and pulmonary metastasis.

Journal: International journal of pharmaceutics: X

Published: February 12, 2024

Showing 1-12 of 15

Last Updated: 09/26/2026